Matches in Wikidata for { <http://www.wikidata.org/entity/Q64189453> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q64189453 description "clinical trial" @default.
- Q64189453 description "ensayu clínicu" @default.
- Q64189453 description "klinisch onderzoek" @default.
- Q64189453 description "клінічне випробування" @default.
- Q64189453 name "A Study Tislelizumab (BGB A317) Combined With Gemcitabine Plus Cisplatin Versus Placebo Combined With Gemcitabine Plus Cisplatin in Recurrent or Metastatic Nasopharyngeal Cancer" @default.
- Q64189453 type Item @default.
- Q64189453 label "A Study Tislelizumab (BGB A317) Combined With Gemcitabine Plus Cisplatin Versus Placebo Combined With Gemcitabine Plus Cisplatin in Recurrent or Metastatic Nasopharyngeal Cancer" @default.
- Q64189453 prefLabel "A Study Tislelizumab (BGB A317) Combined With Gemcitabine Plus Cisplatin Versus Placebo Combined With Gemcitabine Plus Cisplatin in Recurrent or Metastatic Nasopharyngeal Cancer" @default.
- Q64189453 P1132 Q64189453-054F6CF8-6775-4916-B615-7EEF413750BA @default.
- Q64189453 P1476 Q64189453-47D90C3C-FE25-4EF9-BE7C-6D32157FB23B @default.
- Q64189453 P2899 Q64189453-BCDD619A-FDA0-42E6-A25B-E720BA49F028 @default.
- Q64189453 P3098 Q64189453-3469DAE3-4269-4593-AF73-75F2A4B334CC @default.
- Q64189453 P31 Q64189453-50900F8E-C214-4955-AADA-194C8B071C03 @default.
- Q64189453 P4135 Q64189453-4D4CDA3F-B3F2-4DEB-BAB4-E2A484FD925B @default.
- Q64189453 P4844 Q64189453-C2726526-D010-42D6-9DA0-78CCA3C30238 @default.
- Q64189453 P580 Q64189453-0DD0AF25-E096-429D-8361-3A8E6D042E7B @default.
- Q64189453 P582 Q64189453-1C002ECF-FB58-46A6-8C10-60FBC4D1E791 @default.
- Q64189453 P6099 Q64189453-D7218587-242F-4EC5-8514-68BFCC0E58B5 @default.
- Q64189453 P6153 Q64189453-3D18C9E3-FF6E-4425-907C-2EA766F90352 @default.
- Q64189453 P6153 Q64189453-4D9682F9-9795-4BB6-9F12-D8818064BD09 @default.
- Q64189453 P6153 Q64189453-700FC936-62AD-435F-BF8B-A5473E8FADE1 @default.
- Q64189453 P6153 Q64189453-76EA73A6-F470-4916-BCD1-A8913F0E33D1 @default.
- Q64189453 P6153 Q64189453-8B195A19-E30F-4E4F-A39C-ACA1042A7557 @default.
- Q64189453 P6153 Q64189453-96C69D8D-A444-4016-AE1D-01154954B96D @default.
- Q64189453 P6153 Q64189453-BB03DE53-DFFD-4B3C-A1A6-C7282CEC8939 @default.
- Q64189453 P6153 Q64189453-D60A7E07-71FE-45EA-B6CB-17231D02E988 @default.
- Q64189453 P6153 Q64189453-DD1EF98A-8CC8-4EC9-9AA4-0637CE51AE4F @default.
- Q64189453 P6153 Q64189453-E5DBAFA0-A4D3-403C-A86B-1B4F763C9195 @default.
- Q64189453 P6153 Q64189453-F02F95B5-0E8C-4F42-BCF9-956374E610FF @default.
- Q64189453 P6153 Q64189453-FB93012F-EC5D-4833-8498-B02C02456E79 @default.
- Q64189453 P8363 Q64189453-9AD03FB1-5FA3-4C13-8A98-8DD168546779 @default.
- Q64189453 P1132 "+256" @default.
- Q64189453 P1476 "A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-controlled Study to Compare the Efficacy and Safety of Tislelizumab (BGB A317) Combined With Gemcitabine Plus Cisplatin Versus Placebo Combined With Gemcitabine Plus Cisplatin as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer" @default.
- Q64189453 P2899 "+18" @default.
- Q64189453 P3098 "NCT03924986" @default.
- Q64189453 P31 Q30612 @default.
- Q64189453 P4135 "+75" @default.
- Q64189453 P4844 Q412415 @default.
- Q64189453 P580 "2019-04-01T00:00:00Z" @default.
- Q64189453 P582 "2021-08-01T00:00:00Z" @default.
- Q64189453 P6099 Q42824827 @default.
- Q64189453 P6153 Q11070014 @default.
- Q64189453 P6153 Q1418766 @default.
- Q64189453 P6153 Q15901822 @default.
- Q64189453 P6153 Q18111664 @default.
- Q64189453 P6153 Q2748799 @default.
- Q64189453 P6153 Q30253707 @default.
- Q64189453 P6153 Q30254263 @default.
- Q64189453 P6153 Q30269706 @default.
- Q64189453 P6153 Q30269818 @default.
- Q64189453 P6153 Q30296049 @default.
- Q64189453 P6153 Q30296399 @default.
- Q64189453 P6153 Q495015 @default.
- Q64189453 P8363 Q78089383 @default.